BMO Capital analyst Keith Bachman lowered the firm’s price target on HubSpot (HUBS) to $650 from $745 and keeps an Outperform rating on the shares. BMO thinks HubSpot will report modest upside to June quarter revenues and billings estimates and does not think GenAI will negatively impact the company in the near- or medium-term, the analyst tells investors in a research note. The firm cites multiple compression within its software coverage and some lingering macro uncertainty for the price target reduction.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUBS:
- HubSpot price target lowered to $700 from $750 at Stifel
- Salesforce (CRM) Faces Neutral Outlook as Valuation Struggle Sours Investor Sentiment
- HubSpot Approves Governance Changes at Annual Meeting
- HubSpot price target lowered to $675 from $700 at Wells Fargo
- Cantor Says These 2 SaaS Stocks Are Top Picks as AI Rewrites the Software Playbook